Chemed Corp (CHE)
NYSE: CHE · Services-Home Health Care Services · Cincinnati, OH
Our rating: Neutral
Neutral reaffirmed at $534.72, moderate conviction, October 30, 2026.
Breaks if: The Neutral call turns Cautious if net margin falls below 9% for two consecutive quarters — a clear sign that reimbursement pressure or cost inflation is eroding franchise economics the current multiple does not discount. It turns Positive if revenue growth accelerates above 7% and holds there for two consecutive quarters while the FCF yield stays at or above 4%, indicating the growth trajectory has genuinely shifted rather than bouncing from a soft patch.
Key figures
| Market value | $7.1B |
|---|---|
| Revenue, last 12 months | $2.7B |
| Net income, last 12 months | $282M |
| Free cash flow, last 12 months | $295M |
| Price to earnings | 25.3× |
| Free cash flow yield | 4.1% |
| Dividend yield | 0.5% |
| Operating margin | 13.9% |
| Return on equity | 29.1% |
| Beta to the S&P 500 | 0.23 |
| Volatility, annualized | 28.0% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $691M | 10.6% | $5.45 | $38M |
| June 30, 2026 | $673M | 8.8% | $5.13 | $69M |
| March 31, 2026 | $658M | 1.6% | $4.84 | $71M |
| December 31, 2025 | $639M | 55.6% | $5.45 | $117M |
| September 30, 2025 | $625M | 59.7% | $4.46 | $66M |
| June 30, 2025 | $619M | 65.2% | $3.57 | $123M |
| March 31, 2025 | $647M | 82.7% | $4.86 | $19M |
| December 31, 2024 | $411M | 17.4% | $6.01 | $152M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.76B: Claude 25%, Gemini 15%, Mistral 25%
- Diluted earnings per share are at least $5.45: Claude 55%, Gemini 85%, Mistral 50%
- Free cash flow for the quarter is at least $0.12B: Claude 45%, Gemini 35%, Mistral 15%
10 ledger entries and 15 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.